Tarinee Huang
About Tarinee Huang
Tarinee Huang is an Associate Director of Genomics with extensive experience in molecular biology and Next Generation Sequencing. She has held various roles in prominent companies such as Kite Pharma and Admera Health, and she earned her Ph.D. in Biotechnology from Mahidol University in collaboration with Rutgers University.
Current Role at Kite Pharma
Tarinee Huang serves as the Associate Director of Genomics at Kite Pharma, a position she has held since 2022. In this role, she oversees genomic research initiatives and contributes to the development of innovative therapies. Her work focuses on advancing the understanding of genomic data in the context of cancer treatment.
Previous Experience at Kite Pharma
Prior to her current role, Tarinee Huang worked at Kite Pharma as a Senior Manager of Sequencing Technology from 2021 to 2022. During her tenure, she led projects related to sequencing technologies and their applications in genomic research. She initially joined Kite Pharma as a Research Scientist from 2020 to 2021, where she contributed to various research projects.
Experience at Admera Health
Tarinee Huang held multiple positions at Admera Health, including Clinical Scientist II and team leader from 2017 to 2019, and Senior Clinical Scientist in 2019. Her responsibilities included leading clinical research projects and managing teams focused on genomic testing and analysis. She also worked as Scientist II from 2017 to 2018.
Educational Background
Tarinee Huang earned her Doctor of Philosophy (Ph.D.) in Biotechnology through a joint program between Mahidol University in Bangkok, Thailand, and Rutgers University. Her academic background provided her with a strong foundation in molecular biology and biotechnology, which she has applied throughout her career.
Expertise in Molecular Biology and Next Generation Sequencing
Tarinee Huang possesses extensive expertise in molecular biology techniques, particularly in Next Generation Sequencing (NGS). With over six years of experience in NGS, she has developed a specialization that informs her research and leadership in genomic projects. Her background includes roles that required advanced knowledge of sequencing technologies and their applications in clinical and research settings.